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Penicillin-binding proteins (PBPs), which are the lethal targets
of β-lactam antibiotics, catalyse the final stages of peptidoglycan
biosynthesis of the bacterial cell wall. PBP 5 of Escherichia coli is
a D-alanine CPase (carboxypeptidase) that has served as a useful
model to elucidate the catalytic mechanism of low-molecular-
mass PBPs. Previous studies have shown that modification of
Cys115 with a variety of reagents results in a loss of CPase activity
and a large decrease in the rate of deacylation of the penicilloyl–
PBP 5 complex [Tamura, Imae and Strominger (1976) J. Biol.
Chem. 251, 414–423; Curtis and Strominger (1978) J. Biol. Chem.
253, 2584–2588]. The crystal structure of wild-type PBP 5 in
which Cys115 fortuitously had formed a covalent adduct with 2-
mercaptoethanol was solved at 2.0 Å (0.2 nm) resolution, and
these results provide a structural rationale for how thiol-directed
reagents lower the rate of deacylation. When compared with the
structure of the unmodified wild-type enzyme, a major change
in the architecture of the active site is observed. The two largest
differences are the disordering of a loop comprising residues 74–
90 and a shift in residues 106–111, which results in the displace-
ment of Ser110 of the SXN active-site motif. These results support
the developing hypothesis that the SXN motif of PBP 5, and
especially Ser110, is intimately involved in the catalytic mechanism
of deacylation.
Key words: catalytic mechanism, D-alanine carboxypeptidase,
deacylation, Escherichia coli, penicillin-binding protein, X-ray
crystallography.
INTRODUCTION
During the final stages of cell-wall synthesis in bacteria, enzymes
known as penicillin-binding proteins (PBPs) catalyse the cross-
linking of peptide chains from adjacent glycan strands of nascent
peptidoglycan (reviewed in [1–4]). Cross-linking renders the pep-
tidoglycan insoluble and promotes rigidity that helps to create
a barrier against increases in osmotic pressure. As their name
implies, these enzymes are the lethal targets of penicillin and other
β-lactam antibiotics. Penicillin exerts its antimicrobial effect by
forming a long-lived covalent complex with PBPs, which prevents
cross-linking of the peptide chains and leads to cell death. PBPs
can be grouped into two classes: the HMM (high molecular mass)
PBPs, which are considered essential for cell viability, and the
LMM (low molecular mass) PBPs, which are non-essential for
cell viability. Some HMM PBPs are bifunctional enzymes that
catalyse both the transpeptidation of the peptide chains and the
transglycosylation of the glycan strands. In contrast, most LMM
PBPs are D-Ala-D-Ala CPases (carboxypeptidases), which are
thought to regulate the degree of cross-linking by hydrolysing the
ultimate D-alanine residue of the pentapeptide [5]. Some LMM
PBPs can also catalyse transpeptidation in vitro [6,7] but it remains
unclear as to whether this activity also occurs in vivo.
All PBPs are characterized by a set of three conserved sequence
motifs: the SXXK tetrad, which contains the active-site serine
residue that forms a covalent bond with penicillin, the SXN triad
and the KTG triad [8]. These motifs are widely separated in the
primary structure, but come together in the folded protein to form
the active site. Superimpositions of the active sites of the PBPs
of known structure reveal that the active site of one PBP looks
very much like another. Accordingly, the mechanism of catalysis
is likely to be the same within the family of PBPs. PBPs catalyse
a two-step reaction comprising acylation and deacylation. In the
acylation step, the enzyme provides a general base that pulls a
proton from the hydroxy group of a conserved serine residue (in
the SXXK motif), facilitating a nucleophilic attack of the serine
residue on the carbonyl carbon of the pentapeptide substrate.
This attack results in the release of the ultimate D-alanine resi-
due and formation of an acyl-enzyme complex between the PBP
and the penultimate D-alanine residue of the peptide chain. The de-
acylation reaction in PBPs differs depending on whether the PBP
is a transpeptidase (the HMM PBPs) or a CPase (the LMM PBPs).
In transpeptidases, deacylation involves nucleophilic attack by a
free amino group of the acceptor peptide side chain on to the
carbonyl carbon of the acyl-enzyme complex, whereas in CPases
a water molecule acts as the acceptor and the result is a tetrapeptide
product.
PBP 5 from Escherichia coli is one of the best-studied PBPs
and is proving to be an excellent model for probing the catalytic
mechanism of PBPs. PBP 5 is a D-alanine CPase and, although it
is not an essential enzyme, it is important for maintaining correct
bacterial cell morphology [9,10]. Biochemical and structural
studies of both wild-type and mutant forms of this enzyme have
shed light on its catalytic mechanism [11,12]. For the acylation
step, we have proposed that Lys47 of the SXXK tetrad functions
as the general base that abstracts a protein from the reactive
serine, Ser44 [13]. In contrast, a comprehensive understanding
of deacylation has proven more difficult. Indeed, a commonly
accepted mechanism of deacylation for all PBPs remains elusive
(see, e.g., [14,15]).
In order to probe the mechanism of deacylation in PBP 5,
two independent methods, each of which generates an enzyme
Abbreviations used: 2ME, 2-mercaptoethanol; CPase, carboxypeptidase; HMM, high molecular mass; LMM, low molecular mass; p-CMB, p-chloro-
mercuribenzoate; PEG, poly(ethylene glycol); PBP, penicillin-binding protein; R.M.S.D., root mean square deviation.
1 Correspondence may be addressed to either of these authors (email davies@musc.edu or nicholas@med.unc.edu).
The co-ordinates of Cys115-modified PBP 5 (1NZU) and of the mercury-modified PBP 5′ (1SDN) have been deposited in the Protein Data Bank.
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defective in deacylation, have proven useful. The first of these is
a mutant of PBP 5 (termed PBP 5′) deficient in both DD-CPase
activity and deacylation of the penicilloyl–PBP complex [16].
The 30-fold increase in the half-life of the acyl-enzyme complex
with penicillin G [17] is due to a G105D point mutation [18].
Comparison of the crystal structures of both PBP 5′ [11] and the
wild-type enzyme [12] showed that the major difference between
the two enzymes is the disordering of residues 74–90 in the mutant
enzyme, which forms a loop that is adjacent to the active site. The
loss of an interaction between serine residues 86 and 87 on this
loop and the SXN motif in the mutant enzyme pointed to a critical
role for the SXN motif in deacylation [12].
The second approach to create a deacylation-defective variant
of PBP 5 is to treat the wild-type enzyme with thiol-directed
reagents. Much like PBP 5′, thiol derivatization appears to affect
enzyme activity non-symmetrically by inhibiting deacylation,
while acylation is less affected [19,20]. PBP 5 contains only
one cysteine (Cys115) and it was proposed that this residue might
be involved in hydrolysis of the acyl-enzyme complex [21,22].
However, mutating this residue to serine and alanine led to no
significant differences in the rate of penicilloyl-enzyme hydrolysis
or in CPase activity [23]. Thus an alternative hypothesis was
proposed in which modification of Cys115 with bulky thiol reagents
might perturb the three-dimensional structure of the enzyme,
leading to alterations in the architecture of the active site [23].
In the absence of any structural data from PBP 5 in which
Cys115 has been alkylated, however, this hypothesis could not
be examined.
In this study, we present the crystal structure of wild-type PBP
5 in which Cys115 has been covalently modified by 2ME (2-mer-
captoethanol). When compared with the wild-type enzyme, a
large conformational change in the SXN motif is observed as
well as disordering of the 74–90 loop. These results suggest that
both the G105D mutation and cysteine modification generate a
deacylation-defective phenotype in PBP 5 ultimately by affecting
the same region of the active site, namely the SXN motif.
EXPERIMENTAL
Crystallization
A soluble construct of wild-type PBP 5 (sPBP 5) was expressed
and purified as described previously [23]. The protein was stored
at a concentration of 8.4 mg/ml in 20 mM Tris/HCl (pH 7.5),
0.15 M NaCl and 10 mM 2ME. Crystals of sPBP 5 did not grow
using the same solution conditions as for the G105D mutant (PBP
5′) [17]; hence a new crystallization search was undertaken. For
this, a wide variety of solutions were tested, including Crystal
Screens I and II from Hampton Research (Aliso Viejo, CA,
U.S.A.). Some co-crystallization experiments with various β-
lactam antibiotics were also attempted. All of the trials were
conducted using the hanging-drop vapour diffusion method in
which 4 µl of protein was mixed with 4 µl of well solution on a
coverslip and suspended over a 1 ml reservoir. Dishes were stored
at either 18 or 21 ◦C.
Data collection
Crystals of PBP 5 were prepared for data collection by cryo-
protecting in a solution of mother liquor {24% PEG [poly(ethyl-
ene glycol)] 8000, 50 mM sodium citrate, pH 5.5, and 100 mM
magnesium acetate} and glycerol. The glycerol concentration was
gradually increased from 2 to 25% glycerol over a 3 h time
span. Crystals were then flash-cooled in situ at 100 K and data
were collected using a Rigaku RAXIS IV++ image plate system
(Rigaku-MSC) mounted on a Rigaku RU-H3R X-ray generator
equipped with Osmic optics and operating at 50 kV and 100 mA.
A total of 150 images were collected in 1◦ oscillations with
5 min exposure time per frame. The crystal-to-plate distance was
150 mm. Data were processed using CrystalClear [24].
Refinement
Since the crystals generated were, in fact, of the same cell dimen-
sions and space group as those for PBP 5′, the refinement of the
structure commenced with the co-ordinates of PBP 5′, determined
previously at 2.3 Å resolution [11]. After an initial refinement
performed with the CNS [25], 2(|Fobs| − |Fcalc|) and |Fobs| − |Fcalc|
maps were calculated and used to make manual adjustments to
the model using the O program [26]. Further rounds of refinement
were carried out with REFMAC interspersed with manual revision
on O. Water molecules were introduced if suitable peaks of density
were visible in both maps and if they had at least two potential
hydrogen-bonding partners. Two residues (Glu18 and Asn208) were
modelled with two side-chain conformations. Examination of the
structure revealed a molecule of 2ME covalently bound to Cys115
(see the Results section); hence this structure is herein referred to
as 2ME-modified PBP 5. The stereochemistry of the final model
was evaluated using PROCHECK [27] and the numbering of the
amino acids corresponds to the sequence of the mature processed
protein.
Diffraction data for the mercury-modified PBP 5′ were reported
previously [11]. These data were collected from crystals of PBP
5′ that had been soaked in mercury(II) cyanide and are 95.6 %
complete to 2.5 Å resolution. This structure was refined in the
same manner as for the 2ME-modified PBP 5, except that all
side chains were modelled with a single position and fewer water
molecules were included in the final model.
Co-ordinates and structure factors of 2ME-modified PBP 5
(1NZU) and of the mercury-modified PBP 5′ (1SDN) have been
deposited in the Protein Data Bank.
RESULTS
Crystallization and structure determination of 2ME-modified PBP 5
Our initial structural studies of PBP 5 began with PBP 5′,
a deacylation-deficient G105D mutant form of PBP 5, which
formed bullet-shaped crystals in 18–24% PEG 6000 or 8000,
150 mM NaCl and 50 mM Tris/HCl (pH 7) [11]. Attempts to
crystallize the wild-type protein under similar conditions were
not successful, but ultimately they were obtained in solutions
containing 8% PEG 400 buffered with 50 mM Tris/HCl (pH 8)
[12]. The wild-type PBP 5 crystals were of different morphology
than those of PBP 5′ and belonged to a different space group
(C2 for wild-type versus P32 for PBP 5′). However, during the
search for different crystallization conditions, we also obtained
crystals of wild-type PBP 5 in wells containing 24% PEG 8000,
50 mM sodium citrate (pH 5.5) and 100 mM magnesium acetate.
These are similar to the conditions for PBP 5′ but at a lower
pH. The protein drop also contained 1 mM penicillin G, but this
antibiotic was not seen in the final electron-density map (not
shown). The crystals appeared after 3–4 days incubation at 22 ◦C
and were of the same characteristic bullet morphology as crystals
of PBP 5′ [17].
Diffraction studies confirmed that the new crystals were indeed
isomorphous with those of PBP 5′ and belonged to space group
P32 with cell dimensions a = b = 50.3 Å and c = 138.1 Å. The
diffraction data were 99.9% complete at a resolution of 2.0 Å,
and these were used to refine the structure to a final R factor of
21.9% (Rfree = 26.6%) (Table 1). A Ramachandran plot indicated
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Table 1 Data collection and refinement statistics for the 2ME-modified
wild-type PBP 5 and mercury-derivatized PBP 5′
Numbers in parentheses are for the outer shell of data. HgCN, mercury(II) cyanide. Rmerge is
defined as Rmerge = hkl i |Ii (h k l)−〈I(h k l)〉|/hkl i Ii (h k l)].
2ME-modified
Structure wild type PBP 5′–HgCN
Data collection
Resolution range (Å) 41.5–2.0 (2.07–2.0) 25.0–2.5 (2.59–2.5)
No. of measured reflections 74 362 34 123
No. of unique reflections 26 382 13 482
Completeness (%) 99.9 (99.8) 95.6 (88.7)
Mean I/σ I 6.1 (2.0) 11.2 (4.4)
Rmerge (%) 6.5 (30.8) 7.4 (20.3)
Refinement
Resolution range (Å) 15.0–2.0 15.0–2.5
No. of reflections 23 623 13 044
No. of protein atoms 2681 2679
No. of solvent molecules 174 46
R.M.S.D. from ideal stereochemistry
Bond lengths (Å) 0.009 0.011
Bond angles (◦) 1.33 1.27
Mean B value (main chain) (Å3 ) 31.8 29.4
R.M.S.D. in main chain B factors (Å3) 0.47 0.59
Mean B value (side chains) (Å3) 33.4 31.3
R.M.S.D. in side chain B factors (Å3) 1.26 1.46
Mean B value waters (Å3) 35.6 26.4
Crystallographic R factor (%) 21.9 17.4
Rfree (%) 26.6 24.1
Ramachandran plot
Residues in most favoured region (%) 91.7 90.7
Residues in additionally allowed regions (%) 8.0 8.3
Residues in generously allowed regions (%) 0.3 1.0
Residues in disallowed regions (%) 0.0 0.0
that 91.7% of the residues were in the most favoured regions and
8.0% were in additionally allowed regions. Parts of the molecule
corresponding to regions of poor electron density were omitted
from the model. These are residues 1 and 2 at the N-terminus,
the last residue at the C-terminus and a surface loop comprising
residues 79–84.
Careful scrutiny of the |Fobs| − |Fcalc| map revealed positive
electron density adjacent to the thiol group of Cys115, suggesting
that residue was covalently modified (Figure 1a). The size and
shape of this additional density is consistent with this being a
molecule of 2ME. This modification had probably occurred during
the protein preparation in which 100 mM 2ME was present du-
ring elution of PBP 5 from an ampicillin affinity column [23] and
the length of time that had elapsed between initial purification
of the protein and the screening for crystallization conditions
(∼21/2 years). Although 2ME is typically added to protein
solutions to protect against oxidation of cysteine residues, there
are examples of crystal structures in which it has had the opposite
effect [28,29].
Structural description of 2ME-modified PBP 5
The overall fold of 2ME-modified PBP 5 is essentially the
same as the wild-type [12] and PBP 5′ structures [11]. Briefly,
PBP 5 comprises two domains. Domain 1 has a typical trans-
peptidase/penicillin-binding fold found in all PBPs and contains
the active site, whereas domain 2 is mostly β-structure and
may serve simply to project the active domain away from the
cytoplasmic membrane and towards the peptidoglycan substrate.
Superimposition of all the Cα atoms of this structure with those
of the wild-type enzyme resulted in an R.M.S.D. (root mean
square deviation) of 1.2 Å, indicating the close similarity between
the two structures. When only the penicillin-binding domains
are compared, they superimpose with an R.M.S.D. of 0.83 Å
(Figure 2a). Similar values were obtained when the structures
of Cys115-modified PBP 5 and PBP 5′ were compared.
All of the major structural differences are located in the active-
site region. First, the 2ME-modified PBP 5 structure shows
disorder in the 74–90 region, located between α3 and α4, with
a total absence of density for residues 79–84 and weak electron
density for residues 85–90. These same residues show a similar
level of disorder in the structure of PBP 5′, whereas they are
ordered in the structure of the wild-type enzyme. Secondly,
differences are observed in residues 155–158 of the -like loop, so
named with reference to its spatial overlap with the  loop in class
A and C β-lactamases (Figure 2b). However, since this region
exhibits relatively weak density, the differences observed are more
likely due to the difficulty in fitting the model in this region.
Finally, the most significant difference in the 2ME-modified
enzyme, when compared with either the wild-type enzyme or
PBP 5′, occurs in the vicinity of Cys115, as described below.
Cys115 projects into a hydrophobic core region between α2,
α4 and α5 comprising residues Ile106, Met118, Ile54, Thr50 and the
aliphatic part of the side chain of Lys47. Given this arrangement,
the structural effect of adding a bulky group to Cys115 is, as ex-
pected, dramatic. The presence of 2ME covalently attached to
Cys115 results in a clash with Ile106, causing the latter to be dis-
placed (Figure 1a). In fact, the net effect is that the 2ME group
replaces the side chain of Ile106 within the hydrophobic core
region. This, in turn, leads to a shunt of five consecutive residues,
beginning at Ile106 and continuing until Ser110. The consequence
of this change is that α4 terminates one residue earlier (at Leu108
rather than at Gln109) in 2ME-modified PBP 5 than in the wild-
type enzyme, such that the latter half of α4 is closer to a 3/10
helix in conformation rather than an α helix. The most significant
result of this structural alteration is in the position of Ser110 of the
conserved SXN active-site motif, which has moved a considerable
distance away from the active-site cavity and now is exposed
to solvent on the surface of the protein. In so doing, its Cα
carbon has moved 5 Å and its side-chain hydroxy group has
moved 10 Å. This movement dramatically alters the network of
interactions connecting residues of the active site (see below).
Surprisingly, even though the displacement in Ser110 is large,
the correspondence between the two structures is restored very
abruptly at Gly111.
Structure determination of PBP 5′ modified with mercury
The modification of Cys115 by 2ME in wild-type PBP 5 prompted
us to re-examine diffraction data of a mercury derivative used to
determine the crystal structure of PBP 5′ [11], to see whether a
similar modification had occurred in this protein. The structure
of mercury-modified PBP 5′ was generated by refining against
these data, producing a model with a final R factor of 17.4%
(Rfree = 24.1%) (Table 1). As was the case with the Cys115-
modified enzyme, a large portion of the surface loop (74–83)
was not modelled because of poor electron density. A large peak
of positive |Fobs| − |Fcalc| density was observed next to Cys115,
confirming that this residue had been modified by mercury (Fig-
ure 1b). The mercury is positioned at a distance of 2.5 Å from the
sulphur atom of Cys115 and 2.0 Å from the carboxylate oxygen of
Asp105. This latter interaction is specific to PBP 5′ because, in
the wild-type enzyme, this residue is a glycine. Most pertinently,
though, the same shunt of residues 106–110 is observed in this
structure compared with the 2ME-modified structure, demon-
strating that alkylation at Cys115 either by mercury or by 2ME
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Figure 1 Structural effect in PBP 5 of covalent modification of Cys115 by 2ME and in PBP 5′ by mercury
In both stereo views, residues 105–115 of wild-type PBP 5 (coloured grey) are shown superimposed on to the same residues in (a) the wild-type PBP 5 (coloured gold) in which Cys115 is modified
by 2ME and (b) PBP 5-G105D (PBP 5′) (also coloured gold) in which Cys115 is modified by a mercury atom. In both cases, the same shift in residues 106–111 occurs due to the presence of 2ME or
mercury at position 115 abutting Ile106. In both cases, the |F o| − |F c| difference electron density corresponding to 2ME or mercury is shown in green (calculated after refinement against co-ordinates
in which these moieties were absent) and is contoured at 2 and 9 sigma, respectively. This Figure was prepared using PYMOL (http://pymol.sourceforge.net).
has the same structural effect on the protein. In fact, the 2ME-
modified PBP 5 and mercury-modified PBP 5′ are highly similar:
the R.M.S.D. between all main chain Cα atoms is 0.52 Å.
Importantly, essentially the same perturbation occurs to the SXN
motif (Figure 1b), and the hydrogen-bonding networks (not
shown) are very similar in both active sites.
Hydrogen-bonding network in the active site
In 2ME-modified PBP 5, the movement of Ser110 has led to a major
alteration in the hydrogen-bonding arrangement of the active
site when compared with either wild-type PBP 5 or the PBP 5′
mutant, which have essentially the same arrangement (Figure 3).
In the wild-type and PBP 5′ enzymes, the γ hydroxy group of
Ser110 forms a hydrogen bond with Lys213 [11,12], but in the
structure of the modified enzyme this bond is broken and Ser110 is
now exposed on the surface of the molecule, beyond hydrogen-
bonding distance of any other amino acid. Lys213 also loses a
hydrogen bond with the carbonyl group of Ile106 (adjacent to the
site of modification at Cys115), but a slight movement of its residue
now permits a new interaction with Ser44.
The hydrogen-bonding interactions involving Lys47 are also
altered. In the wild-type structure of PBP 5, the ε-amino group of
Lys47 is within hydrogen-bonding distance of the hydroxy group
of Ser44, the amide group of Asn112 and the carbonyl of His151.
In the 2ME-modified enzyme, however, a slight movement of
the side chains of Lys47 and Ser44 results in the breakage of the
hydrogen bond between these two residues. In addition, the hydro-
gen bond between the ε-amino group of Lys47 and the carbonyl
oxygen of His151 is lost and a new one has formed between the
ε-amino group of Lys47 and the carbonyl of Ser110.
DISCUSSION
The first crystal structure for PBP 5 was of a G105D mutant,
termed PBP 5′, which displays a 30-fold decrease in the rate of
deacylation of the penicilloyl-enzyme complex [11,17]. When
compared with the structure of the wild-type enzyme, the major
difference is the disordering of residues 74–90 in PBP 5′ [12].
This disordering was attributed to the disruption of a hydrophobic
core region (comprising α4, α5, β7, β8 and the 74–90 loop) by
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Figure 2 Structural comparison of wild-type, G105D mutant (PBP 5′) and Cys115-modified PBP 5 enzymes
(a) A superimposition of the Cα backbones of wild-type (black), PBP 5′ (light grey) and Cys115 (2ME)-modified PBP 5 (intermediate grey), showing the similarity of the overall folds of the three
structures. The arrow indicates the active-site region where most of the structural differences occur. (b) Stereo representation of the same superimposition showing structural differences in the
active-site region. The Cα atoms of key residues of the three active-site motifs are shown as small spheres. Note the large change in the structure of the SXN motif in Cys115-modified PBP 5 as
indicated by the arrow. This Figure was prepared with MOLSCRIPT [47] and RASTER3D [48].
Asp105, ultimately leading to the loss of contacts between two
serines (Ser86 and Ser87) present on the 74–90 loop and Ser110
and Asn112 of the SXN motif [12]. This result suggested that the
primary mechanism for the defect in deacylation was the loss of
order of the 74–90 region. In support of this hypothesis, deletion
of the 74–90 region in PBP 5 resulted in a decrease in the rate of
deacylation to the same extent as in PBP 5′ [12].
A second method to produce a deacylation-defective PBP 5 is
by treatment of the enzyme with thiol-directed agents [19,20].
The likely target in PBP 5 for such agents is Cys115, which
is the only cysteine residue in PBP 5. Interestingly, Cys115 lies
very close to Gly105, suggesting that the defect in deacylation in
both PBP 5′ and thiol-modified PBP 5 may be the result of the
same mechanism. The structure of Cys115-modified PBP 5 pre-
sented here allows an examination of this hypothesis.
This new structure of PBP 5 arose from efforts to determine the
crystal structure of wild-type PBP 5, culminating in a structure
solved from crystals grown in space group C2 [12]. Wild-
type PBP 5 crystallized under very different conditions from
those for PBP 5′, which crystallized in space group P32 [17]. Sur-
prisingly, an older preparation of the wild-type protein crystallized
under similar conditions to PBP 5′, and crystals were of the
same space group (P32). In this structure, Cys115 is modified by
2ME and, importantly, the 74–90 region shows a similar level
of disorder as seen in PBP 5′. These results are consistent with
the disordering of residues 74–90 being the primary cause of
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Figure 3 Hydrogen-bonding networks in the active sites of (A) wild-type PBP 5, (B) PBP 5-G105D (PBP 5′) and (C) Cys115 (2ME)-modified PBP 5, shown as
stereo representations with important residues in bond form
Potential hydrogen bonds are shown as dashed lines. In comparison with the views of wild-type and G105D mutant PBP 5, the Cys115 modification in the 2ME-modified enzyme has caused Ser110 to
be displaced away from the active site and, as a result, its hydrogen bond with Lys213 is lost and Lys213 now contacts Ser44. Note also the altered position of Lys47 in the modified enzyme, which now
contacts the carbonyl of Ser110 instead of His151. This Figure was prepared using PYMOL (pymol.sourceforge.net).
the defect in deacylation. However, such a facile interpretation is
complicated by the presence of an additional structural change,
the large conformational shift in the region encompassing the
SXN motif, because such a dramatic change in the positions of
active-site residues would be expected to have a significant impact
on enzyme activity.
The SXN motif is one of the three active-site motifs that are
common to all PBPs and related penicillin-interacting enzymes
[3]. Following covalent modification of Cys115, the conformation
of the SXN motif is altered significantly due to a large shift of
Ser110 away from the active site and the loss of a hydrogen bond
with Lys213 (from the KTG motif) that is present in the wild-
type enzyme. Given the high degree of conservation of the SXN
motif and the critical interactions made by Ser110 in the active
site, it seems surprising that when PBP 5 is treated with the thiol
reagent p-CMB (p-chloromercuribenzoate), which presumably is
also directed against Cys115, the enzyme would show any activity
at all, either acylation or deacylation. Indeed, mutation of Ser110
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to Ala leads to a mutant protein with severely decreased activities
for both of these reactions [30].
One explanation for this apparent discrepancy is that the shift
in the SXN motif seen in the crystal structure does not occur
when PBP 5 is treated with p-CMB [20]. However, since the
2ME group on Cys115 directly causes the displacement of the side
chain of Ile106 from a hydrophobic core region, with the con-
comitant shunt of residues 106–110, this explanation seems
implausible because the large size of a mercury atom would
likely have the same effect. This prompted us to re-examine
diffraction data collected from crystals of PBP 5′ derivatized with
mercury(II) cyanide that were used to solve that structure [11].
A structure generated from refinement against these data shows
that Cys115 is indeed derivatized by mercury and that the same
shift of the SXN motif had occurred (Figure 1b). Unfortunately,
attempts to solve the structure of wild-type PBP 5 treated
with mercury derivatives (either by soaking of the crystals or
by co-crystallization trials) were unsuccessful. Furthermore, the
serendipitous nature of the derivatization of the wild-type enzyme
with 2ME precludes reproducing this protein preparation for the
purposes of determining the kinetic properties of a 2ME-modified
PBP 5. Nevertheless, although a direct correlation between the
crystal structure of Cys115-modified PBP 5 and kinetic data is not
possible, it is reasonable to assume that the same shift in the SXN
motif occurred in wild-type PBP 5 when treated with p-CMB.
How then can such an enzyme retain activity for acylation by
penicillin? One explanation consistent with the data is that when
Cys115 of PBP 5 in solution is modified by p-CMB or 2ME, the
SXN motif has a propensity to exist in two conformations: a
native conformation, as observed in wild-type PBP 5 and PBP
5′, and a non-native conformation, as observed in the structure of
the 2ME-modified enzyme and the mercury derivative of PBP 5′.
However, when the protein is organized within a crystal lattice,
only the non-native form is trapped. When the SXN motif occupies
a position resembling the native protein, the enzyme can still be
acylated by penicillin while the acyl-enzyme complex remains
defective for deacylation due to disorder of the 74–90 loop. Hence,
by switching between the two conformations, p-CMB-treated
PBP 5 retains some activity for acylation, whereas the S110A
mutant is essentially inactive because it has lost a functional
group that mediates important hydrogen-bonding interactions.
Such a hypothesis is consistent with current ideas regarding the
catalytic mechanism of PBP 5, because acylation is believed to be
mediated by Lys47 [13], which moves relatively little in the Cys115-
modified enzyme, whereas Ser110 is thought to play a major role
in deacylation (see below).
Interestingly, a localized disordering of the equivalent region
was observed in the structure of a penicillin-resistant variant
of PBP 2x from Streptococcus pneumoniae that also caused a
displacement of Ser395 (equivalent to Ser110 in PBP 5) away from
the active site [31]. The fact that the same region is ordered in the
penicillin-sensitive form of the enzyme [32,33] suggests that an
alteration of structure in this region may in fact have an effect on
acylation by β-lactam antibiotics. However, the PBP 2x system
is complicated by the large number of mutations between the
penicillin-sensitive and -resistant forms of the enzyme, making
it difficult to dissect the individual contributions of each of the
83 amino acid substitutions towards the altered enzyme activity.
Nevertheless, it does show that, under certain conditions, the
region prior to the SXN motif can change structure in other PBPs.
Another issue that requires explanation is how modification
of Cys115 leads to disorder in the 74–90 region of the modified
enzyme. One possibility is that the flexibility of this loop is
simply a property of different crystal packing interactions in
the P32 crystal form of PBP 5, as opposed to those in the C2
form of crystals used to determine the structure of the wild-
type enzyme (in which the 74–90 loop is well ordered). Arguing
against this, though, a structure of PBP 5′ solved from crystals
of space group P1, which manifests a wholly different crystal
packing arrangement compared with the same enzyme solved
in the P32 space group, also shows the same disordering of the
74–90 loop (results not shown). Thus these results suggest that
the disordering of this region exists before crystallization of the
protein. In the crystal structure of PBP 5′, the mechanism of
disordering was clear: the aspartate residue at position 105 (in
place of glycine in the wild-type enzyme) clashed with Leu88 and
Met88, displacing these residues and the surrounding 74–90 region
[12]. A similar mechanism is less obvious in the Cys115-modified
enzyme, because there is a glycine residue at position 105 and the
presence of 2ME has not directly affected any residue other than
Ile106. However, the shunting of residues 106–110 leads to the loss
of hydrogen bonds between the side chain of Gln109 and the
carbonyl group of Leu88 and between the carbonyl group of Gln109
and Ser87, and the loss of these interactions may be responsible
for the disordering of the 74–90 loop (Figure 4). Hence, although
the routes may be different, modification of Cys115 by 2ME in
wild-type PBP 5 or mutation of Gly105 to Asp in PBP 5′ both lead
to a disordering of the 74–90 region. Because the 2ME at Cys115
clashes with Ile106, this modification has the additional effect of
altering residues 106–110 with a dramatic change in the structure
of the SXN motif, whereas an aspartate residue at 105 in PBP 5′
results only in disordering of the 74–90 loop.
Taken together, the three crystal structures of PBP 5 suggest
that both means of producing a deacylation-defective enzyme (by
either mutation at position 105 or modification of Cys115) lead to
disordering of the 74–90 region and the loss of interactions with
the SXN motif. Irrespective of whether the large shift in the SXN
motif observed in the Cys115-modified enzyme is also linked to
the defect in deacylation, all data point to a role for the SXN motif
in the mechanism of deacylation.
The catalytic mechanism underlying the enzymatic activity of
PBPs remains a subject of debate. The reaction comprises two
steps, acylation and deacylation, and neither of these are under-
stood at the mechanistic level. In keeping with the mechanism
first proposed for class A β-lactamases [34] and later extended to
PBPs [15,35,36], one hypothesis for the mechanism of acylation
in PBP 5 is that Lys47 is the general base that abstracts a proton
from Ser44, activating the latter for nucleophilic attack on the
carbonyl carbon of the penultimate D-Ala of the peptide substrate
[13]. However, an alternative mechanism involving transfer of the
proton from the serine nucleophile to the serine residue of
the SXN motif, with concomitant transfer of a proton from the
serine residue of the SXN motif to the β-lactam leaving
group, has also been discussed in the context of other PBPs
[33,37–39].
Even less is known about the mechanism of deacylation in
PBPs. Initial hypotheses focused on a loop in the active site
of PBPs that is spatially equivalent to the  loop of class A
β-lactamases, because in these enzymes this loop contains both
Glu166 and Asn170 that are believed to orientate a hydrolytic water
molecule during deacylation [40–43]. It was suggested, first for
PBP 5 [11], and later for pneumococcal PBP 2x [44] and the
K15 DD-transpeptidase [15], that the equivalent loop may contain
the catalytic machinery for deacylation. Subsequent structural
and mutagenesis data in PBP 5, however, suggested instead that
the SXN motif, and not the -like loop, is intimately involved
in deacylation [12,45]. Based on a crystal structure of PBP 5 in
complex with the peptide-boronic acid, we have proposed
a mechanism for deacylation in which Ser110 polarizes the
hydrolytic water molecule through a hydrogen-bonding network
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Figure 4 The loss of two hydrogen bonds as a result of the shift in the SXN motif contributes to disordering of the 74–90 region in Cys115-modified PBP 5
In this stereo view, wild-type PBP 5 is represented by a grey backbone and side chains, whereas 2ME-modified PBP 5 is shown in orange. In wild-type PBP 5, there are two potential hydrogen
bonds (shown as dashed lines) that link the SXN motif with the 74–90 region, which is fully ordered. In 2ME-modified PBP 5, these bonds are absent due to the shift in residues 106–111 induced
by the 2ME alkylating Cys115, and their loss is hypothesized to lead to destabilization and disordering of the 74–90 loop. Residues that differ significantly in position between the two structures are
coloured grey for wild-type and orange for 2ME-modified PBP 5. This Figure was prepared with MOLSCRIPT [47] and RASTER3D [48].
comprising Ser87, Ser110, Lys213 and a bridging water molecule
[45]. The present work, which points to an altered environment of
the SXN motif in deacylation-defective variants of PBP 5 and, in
particular, the loss of a hydrogen bond between Ser110 and Lys213,
supports this hypothesis. Moreover, the equivalent motif of the
SXN triad in the R61 DD-peptidase, which contains tyrosine in
place of serine, is also believed to be responsible for deacylation
in that enzyme [46]. In PBP 5 that is defective in deacylation, the
loss of critical interactions between the SXN motif and Ser86 and
Ser87 impairs the ability of Ser110 to function within this network.
It appears that a similar mechanism is at play when deacylation
in PBP 5 is impaired by treatment of the enzyme with alkylating
agents.
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